Telephone assessment service for patients receiving ipilimumab for metastatic melanoma

11th December 2015

At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Joanne Upton, Skin Cancer Advanced Nurse Practitioner at The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK, discusses the development of a nurse-led, pre-treatment, telephone assessment service to address waiting times for patients receiving ipilimumab for metastatic melanoma.

Telephone assessment service for patients receiving ipilimumab for metastatic melanoma

Targeting Fibroblast Growth Factor Receptor Alterations in Cholangiocarcinoma and Other Solid Tumours: A New Frontier in Personalised Medicine

EGFR-Mutant Non-small Cell Lung Cancer: State-of-the-Art and Future Perspectives

More articles

EGFR-Mutant Non-small Cell Lung Cancer: State-of-the-Art and Future Perspectives

Infographic: ESMO Recommendations for Diagnosis and Staging of Metastatic Non-Small-Cell Lung Cancer

Novel Biomarkers and Drug Targets in Non-Small Cell Lung Cancer

Featured journals

EMJ Oncology 10 [Supplement 12] 2022

EMJ Oncology 10 [Supplement 11] 2022

Therapeutic Area

About Us

Telephone assessment service for patients receiving ipilimumab for metastatic melanoma

Related To This Subject

Targeting Fibroblast Growth Factor Receptor Alterations in Cholangiocarcinoma and Other Solid Tumours: A New Frontier in Personalised Medicine

EGFR-Mutant Non-small Cell Lung Cancer: State-of-the-Art and Future Perspectives

More articles

EGFR-Mutant Non-small Cell Lung Cancer: State-of-the-Art and Future Perspectives

Infographic: ESMO Recommendations for Diagnosis and Staging of Metastatic Non-Small-Cell Lung Cancer

Novel Biomarkers and Drug Targets in Non-Small Cell Lung Cancer

Featured journals

EMJ Oncology 10 [Supplement 12] 2022

EMJ Oncology 10 [Supplement 11] 2022

Join our mailing list